AHA, NILA Flag Concerning Actions by UnitedHealthcare

The National Independent Laboratory Association and American Hospital Association, bring to the attention of  the National Association of Insurance Commissioners, deeply concerning actions by UnitedHealthcare (UHC) to implement a new plan benefit design that will mislead patients and limit access to needed laboratory services. UHC’s Designated Diagnostic Provider (DDP) program, while couched in the terms of efficiency and quality, effectively creates a tiered benefit design under which patients would be unable to access services provided by in-network hospital and independent laboratories. Under this benefit design, UHC would effectively eliminate coverage for diagnostic tests at all independent and hospital laboratories, including those within its network, unless the facilities agree to participate in the DDP program. To date, UHC has only announced its intention to implement this plan design at the state level, subject to approval by state insurance regulators. For that reason, we urge the attention and opposition of the National Association of Insurance Commissioners (NAIC) and insurance commissioners in all states to implementation of this plan design. View the entire letter below.

Related Resources

Special Bulletin
Public
After concerns raised by the AHA and other health groups, UnitedHealthcare today announced that it would delay until the end of the COVID-19 public health…
Letter/Comment
America’s hospitals and health systems are deeply concerned by UnitedHealthcare’s (UHC) recent policy announcement to allow for the retroactive denial of…
Fact Sheets
Some employers are moving away from offering traditional coverage with a provider network and instead are using reference-based pricing for some or all of…
Special Bulletin
Public
The AHA expresses concern to UnitedHealthcare regarding its recent policy announcement to allow for the retroactive denial of coverage for emergency-level care…
Letter/Comment
Public
The AHA and American Society of Health-System Pharmacists urge the Food and Drug Administration to take appropriate enforcement action to protect patients from…
Letter/Comment
Member
AHA urges the Centers for Medicare & Medicaid Services to align the Hospital Price Transparency Rule with new transparency requirements included in the No…